Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -21.12% | -30.75% | -31.76% | -23.60% | -6.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.12% | -30.75% | -31.76% | -23.60% | -6.79% |
| Cost of Revenue | -21.30% | -30.07% | -31.48% | -21.98% | -11.18% |
| Gross Profit | -20.27% | -33.86% | -33.11% | -31.54% | 21.51% |
| SG&A Expenses | 0.40% | -3.13% | -2.79% | 1.89% | 10.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.19% | -25.39% | -26.70% | -18.25% | -8.42% |
| Operating Income | -250.08% | -941.08% | -871.55% | -929.66% | 58.23% |
| Income Before Tax | -142.21% | -1,946.97% | -1,007.08% | -346.28% | 56.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -142.21% | -1,946.97% | -1,007.08% | -346.28% | 56.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -142.21% | -1,946.97% | -1,007.08% | -346.28% | 56.01% |
| EBIT | -250.08% | -941.08% | -871.55% | -929.66% | 58.23% |
| EBITDA | -371.21% | -196.39% | -189.63% | -194.80% | 201.24% |
| EPS Basic | -75.66% | -632.37% | -339.69% | -175.96% | 55.62% |
| Normalized Basic EPS | -129.68% | -1,992.69% | -674.51% | -212.23% | 65.68% |
| EPS Diluted | -62.75% | -443.49% | -267.07% | -154.43% | 52.19% |
| Normalized Diluted EPS | -124.61% | -1,571.99% | -609.41% | -201.57% | 65.00% |
| Average Basic Shares Outstanding | 16.25% | 15.64% | 15.81% | 14.45% | 14.57% |
| Average Diluted Shares Outstanding | 15.49% | 13.48% | 13.57% | 12.16% | 13.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |